Trials / Completed
CompletedNCT00092989
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Patients With Acute Asthma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 650 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate improved results of treatment for patients entering an emergency department with asthma attacks when given an investigational IV administration of an approved drug (MK-0476, montelukast sodium) in addition to approved standard treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Duration of Treatment: 1 dose |
| DRUG | placebo | Duration of Treatment: 1 dose |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2004-09-29
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092989. Inclusion in this directory is not an endorsement.